3Chow KV,Carroll R,Branley P,et al.Anti-20antibody in thrombotic thrombocytopenic purpura refractory to plasma exchange.Intern Med,2007,37(5):329-332.
二级参考文献12
1[1]Amorosi EL,Ultamann J.E and F.A.C.P. Thrombotic thrombocytopenic purpura: Report of 16 cases and review of the literature.Medicine, 1966,45:139.
2[2]Bums ER, Zucker-Frankling D. Pathologic effects of plasma from patients with thrombotic thrombocytopenic purpura on platelets and cultured vascular endothelial cells. Blood, 1982,60:1030.
3[3]Moake JL. TTP-desperation, empiricism, progress. N Engl J Med, 1991,325:426.
4[4]Tsai HM, Lian EC. Antibodies to von Willebrand factor-cleaving proteaes in acute thrombotic thrombocytopenic purpura. N Engl J Med,1998,339:1585.
5[5]Furlan M, Robles R, Galbusera M, et al. von Willebrand factor -cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med, 1998,339:1578.
6[6]Fujikawa K, Suzuki H, McMullen B,et al. Purification of human von Willebrand factor-cleaving protease and its identification as a new member of the metalloproteinase family. Blood,2001,98:1662.
7[7]Gerritsen HE,Robles R, Lammle B,et al. Partial amino acid sequence of purified von Willebrand factor-cleaving protease . Blood, 2001,98:1654.
8[8]Schultz DR, Arnold PI, Jy W, et al. Anti-CD36 autoantibodies in thrombotic thrombocytopenic purpura and other thrombotic disorders:identification of an 85 KD form of CD36 as a target antingen. Br J Haematol, 1998,103:849.
9[9]Bell WR, Braine HG, Ness PM,et al. Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.Clincal experience in 108 patients. N Engl J Med, 1991,325:398.
10[10]Sarode R, Gottschall JL, Aster RH,et al. Thrombotic thrombocytopenic purpura:early and late responders. AM J Haematol.1997,54:102.
